The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity.
Interesting video about prevention of Corona virus transmision
The first symposium on heart transplantation will take place on February 30, 2020 from 7:30 am to 6:30 pm in the conference hall of Abu Ali Sina Hospital in Sadra.
The seminar "New Drugs in the Control and Treatment of Type 2 Diabetes with Cardiac Benefits" will be held on January 22, 2020 at the Homa Hotel from 17:30 to 22:00.
Seminar on Antiplatelet Therapeutic News on December 12, 2019 by Fars Province Heart Association
PowerPoints are attached
The meeting of the General Assembly of the Association was held on December 12, 2019 at the Wesal Hall of the Grand Hotel Shiraz with the participation of its members and officials.
Fars Heart Aassociation, Cardiology Department, Namazi hospital, Karim Khan Zand Blvd, Shiraz, Fars Province
36125609 - 071
36125601 - 071